University of Florida, U.S.
Bone mineral density changes may reverse after discontinuing depot medroxyprogesterone acetate
Published in Hospital and Nursing Home Week, October 5th, 2006
Researchers writing in the journal Contraception reported, "This 7-year, prospective, matched-cohort, clinical study evaluated the effects of intramuscular depot medroxyprogesterone acetate (DMPA) (150 mg/mL) on bone mineral density (BMD) in women aged 25-35 years."
A.M. Kaunitz and colleagues of the University of Florida wrote, "Bone mineral density changes in new DMPA-IM users (n=248) were compared with those in women using nonhormonal contraception (n=360) for up to 240 weeks of treatment and 96 weeks of posttreatment follow-up (in subjects...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
More Articles from Hospital and Nursing Home Week
- Artisan Pharma
Artisan Pharma raises $39 million in a series A financing - Finance
Clinics share $1 million in grants from Blue Cross Blue Shield of Michigan, Blue Care Network - Hormos Medical
Findings from Finland, Denmark and the United States in osteoporosis provide new insights - Hospitals & Health Networks
LifeCare Holdings subsidiaries open new Louisiana Hospital, announce plans for Wisconsin facility - Medicare
My Health, My Medicare fall campaign debuts to assist beneficiaries in enrollment - Mergers & Acquisitions
Standard Management signs definitive agreement to acquire California pharmacy - More from this issue of Hospital and Nursing Home Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
